Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Varma S, Ozerdem U, Hoda SA. Complexities and challenges in the pathologic assessment of size (T) of invasive breast carcinoma. Adv Anat Pathol. 2014;21(6):420-32.

Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera J-, Reuter VE, et al. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am J Surg Pathol. 2014;38(6):756-67.

Osborne JR, Green DA, Spratt DE, Lyashchenko S, Fareedy SB, Robinson BD, et al. A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy. J Urol. 2014;191(5):1439-45.

Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, et al. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell. 2014;25(5):652-65.

Prandi D, Baca SC, Romanel A, Barbieri CE, Mosquera J-, Fontugne J, et al. Unraveling the clonal hierarchy of somatic genomic aberrations. Genome Biol. 2014;15(8):439.

Shariat SF, Passoni N, Bagrodia A, Rachakonda V, Xylinas E, Robinson B, et al. Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy. BJU Int. 2014;113(1):70-6.

Santagata S, Thakkar A, Ergonul A, Wang B, Woo T, Hu R, et al. Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J Clin Invest. 2014;124(2):859-70.

Caliò A, Nottegar A, Gilioli E, Bria E, Pilotto S, Peretti U, et al. ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lung. J Thorac Oncol. 2014;9(5):729-32.

Lee W, Teckie S, Wiesner T, Ran L, Granada CN, Lin M, et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet. 2014;46(11):1227-32.

Wu R, Zippin JH, Magro C. Double-positive CD4(+)CD8(+) Sézary syndrome: an unusual phenotype with an aggressive clinical course. Cutis. 2014;93(2):E18-25.